In 1997, IGF2BP3 was discovered in a large-scale screen for differentially expressed genes in pancreatic cancer, and it was cloned and initially named as a KH domain-containing protein overexpressed in cancer (KOC) [161]. This evidence concerns the gene IGF2BP3 and familial pancreatic carcinoma.